Zusammenfassung: Im Jahre 2003 sind 17 Medikamente neu zugelassen worden. Es handelt sich um sieben innovative Substanzen mit therapeutischer Relevanz (als Antiemetikum, zur Therapie von Speicherkrankheiten, der Akromegalie, der komplizierten Tibiafraktur, der fortgeschrittenen Osteoporose und von AIDS). F\u00fcnf Substanzen haben zumindest eine verbesserte Pharmakodynamik oder Pharmakokinetik. F\u00fcnf weitere Substanzen sind Molek\u00fclvariationen und als Analogpr\u00e4parate ohne […]<\/p>\n","protected":false},"excerpt":{"rendered":"
Zusammenfassung: Im Jahre 2003 sind 17 Medikamente neu zugelassen worden. Es handelt sich um sieben innovative Substanzen mit therapeutischer Relevanz (als Antiemetikum, zur Therapie von Speicherkrankheiten, der Akromegalie, der komplizierten Tibiafraktur, der fortgeschrittenen Osteoporose und von AIDS). F\u00fcnf Substanzen haben zumindest eine verbesserte Pharmakodynamik oder Pharmakokinetik. F\u00fcnf weitere Substanzen sind Molek\u00fclvariationen und als Analogpr\u00e4parate ohne […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1987,3785,1611,1071,2154,255,523,524,3787,526,73,1355,1360,3784,2782,3786,699,3515,702,2052,1032,1769,3790,257,3788,2793,405,291,3789,3074,115,114,1858,381,378,377,807,1330,3783,1815,520,521,1350],"class_list":["post-1638","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-adalimumab","tag-adefovirdipivoxil","tag-amlodipin","tag-antiemetika","tag-aprepitant","tag-arzneimittel","tag-arzneimittelverordnungen","tag-arzneiverordnungen","tag-arzneiverordnungs-report-2004","tag-buchbesprechung","tag-clopidogrel","tag-cox-2-hemmer","tag-coxibe","tag-dibotermin-alfa","tag-dutasterid","tag-emcitritabin","tag-emesis","tag-enfuvirtid","tag-erbrechen","tag-escitalopram","tag-esomeprazol","tag-interferon-beta-1a","tag-laronidase","tag-medikamente","tag-miglustat","tag-norelgestromin","tag-olanzapin","tag-pantoprazol","tag-pegfilgrastim","tag-pegvisomant","tag-protonenpumpen-hemmer","tag-protonenpumpenhemmer","tag-rofecoxib","tag-selektive-serotonin-wiederaufnahme-hemmer","tag-serotonin-wiederaufnahme-hemmer","tag-ssri","tag-tadalafil","tag-teriparatid","tag-valdecoxib","tag-vardenafil","tag-verordnungsverhalten","tag-verschreibungsverhalten","tag-zyklooxygenase-2-hemmer"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1638"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1638\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1638"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}